Advertisement

We need your help now

Support from readers like you keeps The Journal open.

You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.

If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.

Alamy Stock Photo

UK approves ‘life-saving’ Pfizer antiviral to help at-risk Covid-19 patients

Paxlovid can reduce the risks of being admitted to hospital and death in people with mild to moderate infection.

THE UK HAS approved the use of Pfizer’s Covid-19 antiviral after it was found to help prevent the virus from multiplying in at-risk sufferers.

The Medicines and Healthcare products Regulatory Agency (MHRA) approved a potentially “life-saving” treatment called Paxlovid for use among adults who could be vulnerable to Covid-19 due to age, weight or a prior chronic illness.

The regulator found the drug – which can be taken at home – to be safe and effective at reducing the risks of being admitted to hospital and death in people with mild to moderate infection and who are also at an increased risk of developing severe disease.

In a clinical trial in high-risk adults with symptomatic coronavirus infection, it was found to reduce the risk of being admitted to hospital and of death by almost 90%.

British Health Secretary Sajid Javid said the UK is “one of the first in the world to approve this life-saving antiviral”.

“We are also leading the whole of Europe in the number of antivirals we’ve bought per person – with over 2.75 million courses of this antiviral secured for NHS patients by the Antivirals Taskforce.

“The booster campaign, testing and antiviral defences ensure our country is in the strongest possible position to deal with the threat posed by Omicron as we head into the new year.”

Developed by Pfizer, Paxlovid is an antiviral medicine with a combination of active ingredients, PF-07321332 and ritonavir, that works by inhibiting a protease required for virus replication.

This prevents it from multiplying, keeping virus levels low and helping the body to overcome the viral infection.

The two active substances of Paxlovid come as separate tablets that are packaged together and taken together, twice a day by mouth for five days.

Dr June Raine, MHRA chief executive, said: “Today we have given our regulatory approval for Paxlovid, a Covid-19 treatment found to cut Covid-19 related hospitalisations and deaths by 89% when taken within three days of the start of symptoms.

“We now have a further antiviral medicine for the treatment of Covid-19 that can be taken by mouth rather than administered intravenously.

“This means it can be administered outside a hospital setting, before Covid-19 has progressed to a severe stage.

“I hope the announcement today gives reassurance to those particularly vulnerable to Covid-19, for whom this treatment has been approved. For these individuals, this treatment could be life-saving.”

Based on the clinical trial data, MHRA said it had found Paxlovid is most effective when taken during the early stages of infection.

As such, it recommends its use as soon as possible and within five days of the start of symptoms.

It has been authorised for use in people aged 18 and over who have mild to moderate Covid-19 infection and at least one risk factor for developing severe illness.

Risk factors include obesity, being over 60, diabetes mellitus, or heart disease.

Ben Osborn, country manager at Pfizer UK, said the “at-home therapy, shown in clinical trials to reduce hospitalisations and save lives, has the potential to lessen the devastating impact of a virus that has now taken over five million lives globally”.

Readers like you are keeping these stories free for everyone...
A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation.

View 38 comments
Close
38 Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
Leave a Comment
    Install the app to use these features.
    Mute Dave barrett
    Favourite Dave barrett
    Report
    May 20th 2015, 6:50 AM

    I’m applying for that. So should every one on jobseekers.

    106
    Install the app to use these features.
    Mute right wing
    Favourite right wing
    Report
    May 20th 2015, 6:50 AM

    Plus expenses and pension, who do l give my cv to.
    Forgot l don’t know the right person that holds the tickets to the gravy train.

    87
    Install the app to use these features.
    Mute Mursh
    Favourite Mursh
    Report
    May 20th 2015, 9:09 AM

    Considering you couldn’t figure out where to send your CV I doubt you not knowing the right people would have been the deciding factor in you not getting the job.

    40
    Install the app to use these features.
    Mute John Kennedy
    Favourite John Kennedy
    Report
    May 20th 2015, 9:23 AM

    Mursh, if you know the right people, you don’t need to send a C.V.

    15
    Install the app to use these features.
    Mute Colette Kearns
    Favourite Colette Kearns
    Report
    May 20th 2015, 7:16 AM

    Whos been doing the job for the last 5 months?? & why dont they just keep doing it, and save some money!

    63
    Install the app to use these features.
    Mute Jason Bourne
    Favourite Jason Bourne
    Report
    May 20th 2015, 8:59 AM

    Maybe someone who just qualified for the top up pension and doesn’t need the job anymore. Happens in the public sector all the time.

    19
    Install the app to use these features.
    Mute Tap Solny
    Favourite Tap Solny
    Report
    May 20th 2015, 11:03 AM

    Who or what is a whos?

    3
    Install the app to use these features.
    Mute Mick lennon
    Favourite Mick lennon
    Report
    May 20th 2015, 7:07 AM

    Jobsbridge? Be great to validate this wonderful govnt idea

    58
    Install the app to use these features.
    Mute Trevor Beale
    Favourite Trevor Beale
    Report
    May 20th 2015, 6:43 AM

    Handy number!!

    54
    Install the app to use these features.
    Mute MaryLou(ny)McDonald
    Favourite MaryLou(ny)McDonald
    Report
    May 20th 2015, 1:43 PM

    Ye..O’Brien did a three day week while living in the UK.

    Why do they need 3 Commissioners to run it? It allows for buck passing which is what they did when they fu(ked up the crazy buggung story. Appoint one person to run it and the buck stops with him/her.

    9
    Install the app to use these features.
    Mute Anthony Lang
    Favourite Anthony Lang
    Report
    May 20th 2015, 6:58 AM

    A nightmare job if you attempted to do it properly!

    40
    Install the app to use these features.
    Mute Drew
    Favourite Drew
    Report
    May 20th 2015, 6:55 AM

    Is it bad that that would be a significant paycut for most people I know professionally….

    24
    Install the app to use these features.
    Mute An Ciarraioch
    Favourite An Ciarraioch
    Report
    May 20th 2015, 7:30 AM

    Drew – You can finally come home “from China” ?
    Or is that Wicklow that you are really living in ?

    45
    Install the app to use these features.
    Mute Pearse Mc Mullen
    Favourite Pearse Mc Mullen
    Report
    May 20th 2015, 9:15 AM

    Monopoly money dosen`t count drew….

    13
    Install the app to use these features.
    Mute Tap Solny
    Favourite Tap Solny
    Report
    May 20th 2015, 11:06 AM

    The usual moaners on here moaning. Moaners will moan about anything, they will even moan about having nothing to moan about.

    12
    Install the app to use these features.
    Mute Mary Bibby
    Favourite Mary Bibby
    Report
    May 20th 2015, 12:13 PM

    I’ll do it for half

    1
Submit a report
Please help us understand how this comment violates our community guidelines.
Thank you for the feedback
Your feedback has been sent to our team for review.

Leave a commentcancel

 
JournalTv
News in 60 seconds